<?xml version="1.0" encoding="UTF-8"?>
<?xml-stylesheet href="http://www.msac.gov.au/internet/msac/publishing.nsf/Content/home-1/$FILE/rsstidy.css" type="text/css"?>
<rss version="2.0">
<channel>

<item>
<title>PASC Clinical protocols for public comment  </title>
<description>Application 1147 Implantation of fiducial markers into prostate gland or prostatic surgical bed for radiotherapy (associated anaesthesia)
Application - 1161 First line testing for mutations of epidermal growth factor receptor (EGFR) in patients with metastatic non-small cell lung cancer (NSCLC) for access to gefitinib
Application - 1163 Testing for HER2 status in Gastric Cancer for access to trastuzumab
Application - 1157 Cell enrichment testing for HPV</description>
<link>http://www.msac.gov.au/internet/msac/publishing.nsf/Content/surveys-lp</link>
<pubDate>Mon, 08 August 2011 12:15:00 GMT</pubDate></item>

<item>
<title>Report Released</title>
<link>http://www.msac.gov.au/internet/msac/publishing.nsf/Content/app1143-1</link>
<description>1143 - Radiofrequency Ablation in Barrett's Oesophagus with Dysplasia</description>
<language>en-au</language>
<webMaster>MSAC.SECRETARIAT@health.gov.au</webMaster>
<lastBuildDate>Thu, 30 June 2010 11:00:00 GMT</lastBuildDate>
</item>

<item>  
<title>PASC Meeting Agenda 7 July 2011</title>
<description>App 1147, App 1150, App 1154, App 1157, App 1160, App 1161, App 1163</description>
<link>http://www.msac.gov.au/internet/msac/publishing.nsf/Content/PASC+-+meetings</link>
<pubDate>17 June 2011 12:00:00 GMT</pubDate></item>


</channel></rss>
